Tata Chemicals · NSE: TATACHEM · BSE: 500770

Q4 FY24 results · Jan–Mar 2024

Tata Chemicals reported revenue from operations of ₹3,475.00 crore (down 21.1% from Q4 FY23) and net loss of ₹841.00 crore for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY24Q4 FY23YoYQ3 FY24QoQ
Revenue from operations3,475.004,407.00−21.1%3,730.00−6.8%
Other income114.0075.00+52.0%38.00+200.0%
Total income3,589.004,482.00−19.9%3,768.00−4.8%
Profit before share of associates & JVs and tax(807.00)673.00Turned loss202.00Turned loss
Share of profit/(loss) of associates & JVs11.0013.0060.00
Net profit for the period(841.00)692.00Turned loss194.00Turned loss
Attributable to shareholders of the company(850.00)709.00Turned loss158.00Turned loss
EPS, basic (₹)(33.36)27.83Turned loss6.20Turned loss
Net margin (%)-24.215.75.2

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ4 FY24Q4 FY23YoYQ3 FY24QoQ
Revenue from operations1,090.001,302.00−16.3%1,093.00−0.3%
Other income98.0063.00+55.6%22.00+345.5%
Total income1,188.001,365.00−13.0%1,115.00+6.5%
Profit before tax197.00249.00−20.9%140.00+40.7%
Net profit for the period217.00213.00+1.9%115.00+88.7%
EPS, basic (₹)8.518.35+1.9%4.51+88.7%
Net margin (%)19.916.410.5
Consolidated
Filed with BSE
30 Apr 2024, 12:47 IST
Board meeting
29 Apr 2024
Period
01 Jan 2024 to 31 Mar 2024
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
30 Apr 2024, 12:47 IST
Board meeting
29 Apr 2024
Period
01 Jan 2024 to 31 Mar 2024
Review status
Audited
Source
XBRL filing on BSE